QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 153 filers reported holding QIAGEN NV in Q2 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,602,000 | +1486.2% | 913,670 | +1453.2% | 0.01% | +800.0% |
| Q3 2016 | $1,614,000 | +33.6% | 58,824 | +6.1% | 0.00% | – |
| Q2 2016 | $1,208,000 | +21.0% | 55,425 | +24.0% | 0.00% | – |
| Q1 2016 | $998,000 | -20.2% | 44,683 | -1.2% | 0.00% | – |
| Q4 2015 | $1,250,000 | -55.8% | 45,209 | -58.7% | 0.00% | -100.0% |
| Q3 2015 | $2,827,000 | +61.4% | 109,560 | +54.0% | 0.00% | 0.0% |
| Q2 2015 | $1,752,000 | +63.1% | 71,164 | +67.1% | 0.00% | – |
| Q1 2015 | $1,074,000 | -46.9% | 42,588 | -51.0% | 0.00% | -100.0% |
| Q4 2014 | $2,022,000 | +126.4% | 86,887 | +121.6% | 0.00% | – |
| Q3 2014 | $893,000 | -8.9% | 39,217 | -3.1% | 0.00% | – |
| Q2 2014 | $980,000 | +16.3% | 40,467 | +0.6% | 0.00% | – |
| Q1 2014 | $843,000 | -11.6% | 40,206 | -1.7% | 0.00% | – |
| Q4 2013 | $954,000 | -7.2% | 40,906 | -14.2% | 0.00% | – |
| Q3 2013 | $1,028,000 | +6.1% | 47,673 | -3.5% | 0.00% | – |
| Q2 2013 | $969,000 | – | 49,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simcah Management LLC | 248,425 | $5,915,000 | 6.83% |
| Hardman Johnston Global Advisors LLC | 3,500,284 | $83,342,000 | 5.47% |
| Douglas C. Lane & Associates, Inc. | 1,892,425 | $45,059,000 | 1.50% |
| HARDING LOEVNER LP | 6,997,851 | $166,619,000 | 1.29% |
| CREDIT AGRICOLE S A | 7,703,028 | $183,409,000 | 0.76% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $42,407,000 | 0.73% |
| MANNING & NAPIER ADVISORS LLC | 6,290,930 | $149,784,000 | 0.68% |
| Orbimed Advisors | 1,927,000 | $45,882,000 | 0.67% |
| FIRST NEW YORK SECURITIES LLC /NY | 45,540 | $1,084,000 | 0.66% |
| PRIMECAP MANAGEMENT CO/CA/ | 19,385,944 | $461,579,000 | 0.56% |